iECURE to Present Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM Annual Symposium

/in , /by

August 20, 2026

Read more

iECURE Presents Updated Clinical Data from OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM 2026

/in , /by

August 27, 2026

Read more

Decreased rate of hyperammonemic crises in infants with neonatal-onset OTC deficiency post ECUR-506 administration: Preliminary update from the OTC-HOPE study

/in , /by

https://iecure.com/wp-content/uploads/Ecure_Garrod_Poster_Website.pdf

Decreased rate of hyperammonemiccrises in infants with neonatal-onset OTC deficiency (OTCD) post ECUR-506 administration

/in , /by

https://iecure.com/wp-content/uploads/2026-SSIEM-Platform-Final-Baruteau-aug27.pdf

iECURE Reports Sustained Clinical Response in the First Patient Dosed with ECUR-506 & Reductions in the Annualized Rates of Hyperammonemic Events and Crises in the First Completed Cohort of ECUR-506 in Ongoing OTC-HOPE Trial

/in , /by

May 18, 2026

Read more

Decreased rate of hyperammonemic crises in infants with neonatal-onset OTC deficiency post ECUR-506 administration: preliminary update from the OTC-HOPE study

/in , /by

https://iecure.com/wp-content/uploads/ASGCT-2026_iECURE_Presentation.pdf

iECURE Presents Preliminary Clinical Data from Ongoing Clinical Trial of ECUR-506 in Ornithine Transcarbamylase Deficiency at the ASGCT Annual Meeting

/in , /by

May 13, 2026

Read more

iECURE to Present Preliminary Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at the ASGCT and SIMD Annual Meetings

/in , /by

April 28, 2026

Read more